Phyto Chem Intrinsic Value
Phyto Chem (PHYTO) median intrinsic value is ₹28.00 from 4 valuation models (range ₹15–₹46), vs current price ₹24.35 — +15.0% upside (Trading Below Median Value), margin of safety 13.0%. For current market price and key ratios, visit Phyto Chem share price chart.
PHYTO Valuation Methods Summary — DCF, Graham Number & P/E
Phyto Chem intrinsic value across 4 models vs current price ₹24.35 — upside/downside and value range per method. Browse Phyto Chem financial data for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹15.00 | ₹13.50 - ₹16.50 | -38.4% | Book Value/Share: ₹15.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹28.00 | ₹25.20 - ₹30.80 | +15.0% | Revenue/Share: ₹35.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹15.00 | ₹13.50 - ₹16.50 | -38.4% | EBITDA: ₹1.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹46.42 | ₹37.14 - ₹55.70 | +90.6% | CF Growth: 5.0%, Discount: 15% |
PHYTO Intrinsic Value vs Market Price — All Valuation Models
Phyto Chem fair value range ₹15–₹46 vs current market price ₹24.35 across 4 valuation models. Compare with Phyto Chem valuation methods to assess whether the stock is under or overvalued.
PHYTO Intrinsic Value Analysis — Undervalued or Overvalued?
Phyto Chem median intrinsic value ₹28.00, current price ₹24.35 — Trading Below Median Value by 15.0%, margin of safety 13.0%.
What is the intrinsic value of PHYTO?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Phyto Chem (PHYTO) is ₹28.00 (median value). With the current market price of ₹24.35, this represents a +15.0% variance from our estimated fair value.
The valuation range spans from ₹15.00 to ₹46.42, indicating ₹15.00 - ₹46.42.
Is PHYTO undervalued or overvalued?
Based on our multi-method analysis, Phyto Chem (PHYTO) appears to be trading below median value by approximately 15.0%.
PHYTO Financial Health — Key Ratios vs Industry Benchmarks
Phyto Chem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 12.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 4.67 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -16.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -28.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.50x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
PHYTO Cash Flow Quality — Operating & Free Cash Flow
Phyto Chem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |